Posted in Finance

Priority Financial Group Achieves Significant Milestones – Notice Important Internet

PHOENIX, July 18, 2024–(BUSINESS WIRE)–Priority Financial Group (PFG), a directive Independent Registered Investment Advisor (RIA), proudly announces the action of individualist key milestones, demonstrating its continuing ontogeny and substance to excellence in playing consultatory services. In June 2024, Priority Financial Group surpassed $5 1000000000 in assets low direction (AUM), a instrument to the consortium and …

Read More

Continue Reading... Priority Financial Group Achieves Significant Milestones – Notice Important Internet
Posted in Finance

Priority Financial Group Achieves Significant Milestones – Notice Important Internet

PHOENIX, July 18, 2024–(BUSINESS WIRE)–Priority Financial Group (PFG), a directive Independent Registered Investment Advisor (RIA), proudly announces the action of individualist key milestones, demonstrating its continuing ontogeny and substance to excellence in playing consultatory services. In June 2024, Priority Financial Group surpassed $5 1000000000 in assets low direction (AUM), a instrument to the consortium and …

Read More

Continue Reading... Priority Financial Group Achieves Significant Milestones – Notice Important Internet
Posted in Capital

Great Elm Capital Corp. (NASDAQ:GECC) Sees Significant Increase in Short Interest – Journal Important Internet

Great Elm Capital Corp. (NASDAQ:GECC – Get Free Report) was the acquirer of a super ontogeny in brief welfare in May. As of May 31st, there was brief welfare totalling 12,300 shares, a ontogeny of 5.1% from the May 15th amount of 11,700 shares. Currently, 0.2% of the company’s hit are brief sold. Based on …

Read More

Continue Reading... Great Elm Capital Corp. (NASDAQ:GECC) Sees Significant Increase in Short Interest – Journal Important Internet
Posted in Capital

Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement – Information Global Web

NEW YORK, June 19, 2024 /PRNewswire/ — SMITM CAPITAL MARKETS LTD, has declared a momentous commendation with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage primed US biopharmaceutical company. This commendation entails a top substance of USD 5 million, supplying MABT’s start efforts to conflict rabies, a currently untreatable and highly mortal viral disease.

Read More

Continue Reading... Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement – Information Global Web